StonvexLoading…
StonvexStonvexStonvexCore line items from LILA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2023 2023-06-30 |
|---|---|---|---|---|
Revenue | $4.44B | $4.45B | $4.51B | $2.22B |
Operating Income | $108.20M | $-76.80M | $517.70M | $242.00M |
Net Income | $-611.20M | $-689.40M | $-73.60M | $-30.50M |
EPS (Diluted) | $-3.06 | $-3.47 | $-0.35 | Not available |
Total Assets | $12.23B | $12.78B | $13.59B | Not available |
Total Liabilities | $11.16B | $11.19B | $11.28B | Not available |
Cash & Equivalents | $783.90M | $654.30M | $988.60M | Not available |
Free Cash Flow OCF − CapEx | $305.90M | $215.90M | $312.00M | Not available |
Shares Outstanding | 199.50M | 198.40M | 210.00M | Not available |